Growth Hormone Deficiency
145
9
10
94
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
30 trials with published results (21%)
Research Maturity
94 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
11.0%
16 terminated out of 145 trials
85.5%
-1.1% vs benchmark
32%
46 trials in Phase 3/4
32%
30 of 94 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 94 completed trials
Clinical Trials (145)
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)
Body Composition and Adipose Tissue in HIV
Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)
Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Effects of GH and Lirglutide on AgRP
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Chromosome 18 Clinical Research Center
Growth and Asymmetric diMethylArginine
Skeletal Muscle Effects of GH in Boys
Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy
The AgRP and GH/IGF-1 Axis in Children
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
Adipose Tissue and Serum Inflammation in GH Deficiency
Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone Deficiency
A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
BELux Children OutcoME During A(@)Dulthood With GHD